Nicholas A.J. Botwood
Head of R&D, CMO · Syndax Pharmaceuticals Inc
- 2026
- Jun 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nicholas A.J. Botwood files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael A. Metzger - $1.43M in SNDX purchases and sales in the last 12 months
- Keith A. Goldan - $137K in SNDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nicholas A.J. Botwood?
Nicholas A.J. Botwood is a corporate insider, tracked as Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nicholas A.J. Botwood last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 2 filings going back to 2026.
Has Nicholas A.J. Botwood been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.18M) across all tracked filings.
